113 related articles for article (PubMed ID: 3928107)
1. [Experimental bases of the in vitro treatment of leukemic bone marrow by a derivative of cyclophosphamide: ASTA Z 7557].
Douay L; Gorin NC; Mary JY; Duhamel G
C R Acad Sci III; 1985; 301(6):303-8. PubMed ID: 3928107
[TBL] [Abstract][Full Text] [Related]
2. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
[TBL] [Abstract][Full Text] [Related]
3. [A simple method for detecting immature precursors after in vitro bone marrow treatment with ASTA-Z 7654].
Lamana M; Fernández-Rañada JM
Sangre (Barc); 1991 Dec; 36(6):501-3. PubMed ID: 1812583
[TBL] [Abstract][Full Text] [Related]
4. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213).
Deconinck E; Tamayo E; Hervé P
Bone Marrow Transplant; 1990 Jan; 5(1):13-8. PubMed ID: 2297586
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
[TBL] [Abstract][Full Text] [Related]
6. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557).
Douay L; Mary JY; Giarratana MC; Najman A; Gorin NC
Exp Hematol; 1989 Jun; 17(5):429-32. PubMed ID: 2653856
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
10. Collagen gel cultures for detection of spared hematopoietic progenitors in Asta Z 7557 purged human marrows.
Praloran V; Dobo I; Garand R; Klausman M; Naud MF; Milpied N; Harousseau JL
Leukemia; 1990 Apr; 4(4):282-6. PubMed ID: 2366583
[TBL] [Abstract][Full Text] [Related]
11. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
Murphy PB; Richman CM
Exp Hematol; 1989 Dec; 17(11):1105-9. PubMed ID: 2583254
[TBL] [Abstract][Full Text] [Related]
12. ASTA Z 7557 (INN mafosfamide) for the in vitro treatment of human leukemic bone marrows.
Douay L; Gorin NC; Laporte JP; Lopez M; Najman A; Duhamel G
Invest New Drugs; 1984; 2(2):187-90. PubMed ID: 6381382
[TBL] [Abstract][Full Text] [Related]
13. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
Tamayo E; Hervé P
Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
[TBL] [Abstract][Full Text] [Related]
14. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
15. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
Genevay MC; Mormont C; Thomas F; Berthier R
Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
17. No preferential sensitivity of clonogenic AML cells to ASTA-Z-7557.
Kluin-Nelemans HC; Martens AC; Löwenberg B; Hagenbeek A
Leuk Res; 1984; 8(4):723-8. PubMed ID: 6590937
[TBL] [Abstract][Full Text] [Related]
18. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.
Douay L; Giarratana MC; Labopin M; Bardinet D; Bouchet S; Gorin NC
Bone Marrow Transplant; 1995 May; 15(5):769-75. PubMed ID: 7670404
[TBL] [Abstract][Full Text] [Related]
19. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
20. Long-term bone marrow culture induces terminal differentiation of human myeloid leukemic cells.
Iland HJ; Croaker GM; Repka E; Radloff TJ; Vincent PC
Exp Hematol; 1987 Dec; 15(11):1109-14. PubMed ID: 3479335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
